阿片类药物使用障碍对喘住院的影响:一项倾向匹配的全国性研究
Francisco J Gallegos-Koyner1, Franc Hodo1, Nelson I Barrera1
1St. Barnabas Hospital Health System, Department of Internal Medicine, City University of New York School of Medicine, Bronx, New York.
概括
阿片类药物使用障碍 (OUD) 不会增加喘住院的死亡率. 然而,患有喘和OUD的患者面临更糟糕的二次结果,包括更高的机械呼吸率和更长的住院时间.
科学领域:
- 肺部医学 肺部医学
- 成 药物 药物 药物 药物
- 医疗保健服务研究 医疗服务研究
背景情况:
- 患有喘和阿片类药物使用障碍 (OUD) 的患者面临更高的急性恶化率.
- OUD对喘相关住院病人的影响仍未得到充分研究.
研究的目的:
- 调查与OUD同时使用的成年喘患者的临床结果.
- 为了比较患有OUD和没有OUD的喘患者之间的住院结果.
主要方法:
- 利用国家住院患者样本来识别具有和没有OUD的成年喘患者.
- 雇佣了1:1的倾向分数匹配,以创建可比的队列.
- 专注于住院死亡率作为主要结局.
主要成果:
- 患有OUD和没有OUD的喘患者在住院死亡率上没有显著差异.
- 患有OUD的喘患者经历了更高的机械呼吸和非侵入性呼吸率.
- 患有OUD的患者在住院的平均时间明显长.
结论:
- 同时使用OUD并不会增加喘住院患者的死亡风险.
- 患有OUD的喘患者表现出较差的二次结果,包括增加对呼吸系统支持的需求和延长住院时间.
相关概念视频
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


